Related Experiment Video
Updated: Nov 21, 2025

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Retroperitoneal lymph node dissection for germ cell tumour
Vy Tran1, Luke Gibson1, Shomik Sengupta1,2,3
1Department of Urology, Eastern Health, Box Hill, Victoria, Australia.
Abstract:
Retroperitoneal lymph node dissection (RPLND) is an infrequently used, but important part of the management of men with metastatic germ cell tumours. The surgery aims to remove the lymph nodes from the primary retroperitoneal landing site from testicular tumours, usually accomplished by removing tissue surrounding the great vessels using a split-and-roll technique. RPLND may be carried out as a primary surgical procedure for staging or treatment of metastases. More frequently it is undertaken as a follow-up after chemotherapy for a residual mass that may contain viable tumour or teratoma. RPLND is recognised as a major surgery with significant risks of morbidity and complications, particularly loss of ejaculation secondary to damage to hypogastric nerves. In select cases, especially during primary RPLND, nerve-sparing surgery may help preserve ejaculation, which maybe of importance to the young men usually treated for germ cell tumours. In recent years, the development of minimally invasive approaches have also offered a means for potential improvement in the pain and post-operative recovery from RPLND. We conducted a narrative review of the literature to assess indications for RPLND, along with operative approaches and techniques and related outcomes. The majority of available literature is in the form of relatively small retrospective case series, hence additional research in this area is desirable.
Insights
Retroperitoneal lymph node dissection (RPLND) aids in managing metastatic germ cell tumors by removing lymph nodes. Nerve-sparing techniques and minimally invasive approaches may improve outcomes and reduce complications like loss of ejaculation.
Area of Science:
- Oncology
- Surgical Oncology
- Urology
Background:
- Retroperitoneal lymph node dissection (RPLND) is a critical surgical procedure for managing metastatic germ cell tumors.
- It involves removing lymph nodes from the retroperitoneal area, the common site for testicular tumor metastasis.
Purpose of the Study:
- To review the indications, surgical approaches, techniques, and outcomes of RPLND.
- To assess the potential benefits of nerve-sparing and minimally invasive techniques in RPLND.
Main Methods:
- A narrative review of existing literature was conducted.
- The review assessed studies on RPLND indications, operative techniques, and patient outcomes.
Main Results:
- RPLND is used for staging or treating metastases, often after chemotherapy for residual masses.
- Significant risks include morbidity and loss of ejaculation due to hypogastric nerve damage.
- Nerve-sparing surgery and minimally invasive approaches show potential for improved outcomes and recovery.
Conclusions:
- RPLND is an important but complex surgery for germ cell tumors.
- Further research is needed due to the prevalence of small retrospective studies.
